$ANUHPHR . – Bullish Outlook with Upside Target of ₹86

$ANUHPHR ., a well-established player in the pharmaceutical sector, is showing signs of bullish momentum backed by both strong fundamentals and positive technical indicators. The company has demonstrated steady revenue growth over the past few years, reflecting consistent demand for its products and operational stability. Profitability metrics have improved recently, and with a low debt-to-equity ratio, the company maintains a solid financial position, providing a stable foundation for growth. From a technical perspective, the stock is trading above its 50-day and 200-day moving averages, signaling a strong upward trend. The 14-day RSI is around 58, suggesting healthy buying interest without being overbought, while the MACD is positive, reinforcing the bullish momentum. Bollinger Bands show the price approaching the upper band, indicating strength while allowing room for controlled consolidation. These indicators collectively suggest continued upward movement in the near to medium term. Considering Anuh Pharma’s stable financial performance, growth prospects, and favorable technical setup—including moving averages, RSI, MACD, and Bollinger Bands—the stock appears well-positioned for further gains. A realistic upside target of ₹86 is achievable, making it an attractive opportunity for investors looking for exposure to a fundamentally strong and technically supported pharmaceutical stock.